During the past decade, Cardiovascular Specialist Of South Florida conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Specialist Of South Florida" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Specialist Of South Florida" are "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Cardiovascular Specialist Of South Florida" in a lesser frequency.

Most popular intervention types in "Cardiovascular Specialist Of South Florida" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Placebo" (1 trials), "apixaban" (1 trials) and "warfarin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Specialist Of South Florida" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Specialist Of South Florida". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiovascular Specialist Of South Florida, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Specialist Of South Florida, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".